Prostate Cancer Metastatic Disease

Oncology
1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Halda Therapeutics
Halda TherapeuticsCT - New Haven
1 program
1
HLD-0915Phase 1/21 trial
Active Trials
NCT06800313RecruitingEst. Mar 2027

Trial Timeline

Clinical trial activity over time

2025
2026
2027
Halda TherapeuticsHLD-0915

Clinical Trials (1)

A Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Start: Feb 2025Est. completion: Mar 2027
Phase 1/2Recruiting

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space